Journal
THERANOSTICS
Volume 12, Issue 1, Pages 410-417Publisher
IVYSPRING INT PUBL
DOI: 10.7150/thno.67155
Keywords
gamma-glutamyl transpeptidase; gadolinium nanoparticle; magnetic resonance imaging; liver tumor; tumor imaging
Categories
Funding
- National Natural Science Foundation of China [21725505, 21904002, 22074016]
- Natural Science Foundation of Anhui Province [2008085QB94]
- Clinical Research Incubation Program of the Second Hospital of Anhui Medical University [2020LCZD18]
Ask authors/readers for more resources
This study found that a gadolinium nanoparticle, instructed by gamma-glutamyl transpeptidase (GGT) and formed intracellularly, exhibits different magnetic resonance properties at low and high magnetic fields, making it suitable for enhancing T-1 and T-2 MRI imaging of liver tumors respectively.
Background: Nowadays, magnetic resonance imaging (MRI) is routinely applied in clinical diagnosis. However, using one contrast agent (CA) to simultaneously enhance the T-1 and T-2 MR contrast at low and high magnetic fields respectively has not been reported. Methods: Herein, we investigated the MR property of a gamma-glutamyl transpeptidase (GGT)-instructed, intracellular formed gadolinium nanoparticle (DOTA-Gd-CBT-NP) at low and high magnetic fields. Results: Experimental results showed that DOTA-Gd-CBT-NP possesses a low r(2)/r(1) ratio 0.91 which enables it to enhance T-1 MR imaging of liver tumor at 1.0 T, and a high r(2)/r(1) ratio 11.8 which renders the nanoparticle to largely enhance T-2 MR imaging of liver tumor at 9.4 T. Conclusion: We expect that our GGT-responsive Gd-nanoparticle could be applied for simultaneous T-1 and T-2 MRI diagnosis of early liver cancer in clinic at respective low and high magnetic fields when the 9.4 T MR machine is clinically available in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available